ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.275
-0.01%
Bitcoin
67,887.93
-0.39%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Karuna Therapeutics Inc (KRTX)

  7. Karuna Therapeutics Inc (KRTX) News

KRTX

Karuna Therapeutics (KRTX)

Karuna Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRTX
DateTimeSourceHeadlineSymbolCompany
03/11/20245:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
03/08/20245:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
03/01/20246:02AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
03/01/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
02/22/20246:39AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KRTXKaruna Therapeutics Inc
02/22/20246:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
02/22/20246:30AMBusiness WireKaruna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business UpdateNASDAQ:KRTXKaruna Therapeutics Inc
02/15/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/15/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/15/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/15/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/14/202410:04AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KRTXKaruna Therapeutics Inc
02/12/20245:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/12/20245:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/08/202411:56AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
02/05/20244:12PMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:KRTXKaruna Therapeutics Inc
01/22/20246:05AMEdgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:KRTXKaruna Therapeutics Inc
01/16/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
01/09/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
01/08/20244:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
01/08/202410:06AMPR Newswire (US)Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law FirmNASDAQ:KRTXKaruna Therapeutics Inc
12/29/20234:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20235:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20235:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20235:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20234:28PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20234:22PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20234:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
12/22/20233:30PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc.NASDAQ:KRTXKaruna Therapeutics Inc
12/22/202311:15AMDow Jones NewsTrending: Bristol Myers to Buy Karuna Therapeutics for $14 BillionNASDAQ:KRTXKaruna Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KRTX

Your Recent History

USOTC
BIEL
Bioelectronics (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
NASDAQ
AVXL
Anavex Life Sciences
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
COOP
Mr Cooper
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved